Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naji Salem

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
Bulletin Du Cancer|January 23, 2015
[Metastatic hormone-sensitive prostate cancer]Gwenaelle Gravis, Naji Salem, Jochen Walz
Bulletin Du Cancer|September 13, 2007
[Prostate cancer and chemotherapy]Gwenaelle Gravis, Naji Salem, Franck Bladou, et al.
World Journal of Surgical Oncology|October 1, 2013
Major response with sorafenib in advanced renal cell carcinoma after 14 years of follow-upMathilde Guerin, Naji Salem, Jochen Walz, et al.
In Vivo (Athens, Greece)|December 25, 2017
Early PET-CT After Stereotactic Radiotherapy for Stage 1 Non-small Cell Lung Carcinoma Is Predictive of Local ControlMarguerite Tyran, Nathalie Charrier, Julien Darreon, et al.
World Journal of Urology|May 27, 2011
Identification of the prostate cancer index lesion by real-time elastography: considerations for focal therapy of prostate cancerJochen Walz, Myriam Marcy, Jeanne Thomassin Pianna, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 22, 2003
Predictive factors of acute urinary morbidity after iodine-125 brachytherapy for localised prostate cancer: a phase 2 studyNaji Salem, Michelle Simonian-Sauve, Roland Rosello, et al.
World Journal of Urology|June 13, 2014
Comparison of image-guided targeted biopsies versus systematic randomized biopsies in the detection of prostate cancer: a systematic literature review of well-designed studiesAntoine van Hove, Pierre-Henri Savoie, Charlotte Maurin, et al.
BMC Cancer|November 24, 2018
Long-term efficacy of crizotinib in a metastatic papillary renal carcinoma with MET amplification: a case report and literature reviewPhilippe Rochigneux, Jeanne Thomassin-Piana, Sophy Laibe, et al.
Urology|September 8, 2004
Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapyLuc George, Franck Bladou, Valérie Jeanne Bardou, et al.
World Journal of Urology|June 27, 2020
Metastatic hormone sensitive prostate cancer: local treatment strategiesJochen Walz, Geraldine Pignot, Sami Fakhfakh, et al.
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Bulletin Du Cancer|January 23, 2015
[Metastatic hormone-sensitive prostate cancer]Gwenaelle Gravis, Naji Salem, Jochen Walz
Bulletin Du Cancer|September 13, 2007
[Prostate cancer and chemotherapy]Gwenaelle Gravis, Naji Salem, Franck Bladou, et al.
World Journal of Surgical Oncology|October 1, 2013
Major response with sorafenib in advanced renal cell carcinoma after 14 years of follow-upMathilde Guerin, Naji Salem, Jochen Walz, et al.
In Vivo (Athens, Greece)|December 25, 2017
Early PET-CT After Stereotactic Radiotherapy for Stage 1 Non-small Cell Lung Carcinoma Is Predictive of Local ControlMarguerite Tyran, Nathalie Charrier, Julien Darreon, et al.
World Journal of Urology|May 27, 2011
Identification of the prostate cancer index lesion by real-time elastography: considerations for focal therapy of prostate cancerJochen Walz, Myriam Marcy, Jeanne Thomassin Pianna, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 22, 2003
Predictive factors of acute urinary morbidity after iodine-125 brachytherapy for localised prostate cancer: a phase 2 studyNaji Salem, Michelle Simonian-Sauve, Roland Rosello, et al.
World Journal of Urology|June 13, 2014
Comparison of image-guided targeted biopsies versus systematic randomized biopsies in the detection of prostate cancer: a systematic literature review of well-designed studiesAntoine van Hove, Pierre-Henri Savoie, Charlotte Maurin, et al.
BMC Cancer|November 24, 2018
Long-term efficacy of crizotinib in a metastatic papillary renal carcinoma with MET amplification: a case report and literature reviewPhilippe Rochigneux, Jeanne Thomassin-Piana, Sophy Laibe, et al.
Urology|September 8, 2004
Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapyLuc George, Franck Bladou, Valérie Jeanne Bardou, et al.
World Journal of Urology|June 27, 2020
Metastatic hormone sensitive prostate cancer: local treatment strategiesJochen Walz, Geraldine Pignot, Sami Fakhfakh, et al.
Pageof 7